CMND
Clearmind Medicine Inc. Common SharesNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$2.87M
P/E Ratio
—
EPS
$-24.12
Beta
-1.03
52W High
$52.40
52W Low
$0.59
50-Day MA
$1.26
200-Day MA
$21.32
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Clearmind Medicine Inc. Common Shares
Clearmind Medicine Inc., a preclinical pharmaceutical company, develops new psychedelic drugs to treat neglected health problems. The company is headquartered in Vancouver, Canada.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-7.82M |
| Operating Margin | 0.00% |
| Return on Equity | -119.70% |
| Return on Assets | -55.20% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $5.49 |
| Price-to-Book | 0.31 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -0.79 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $2.39M |
| Float | $2.04M |
| % Insiders | 4.46% |
| % Institutions | 0.44% |
Historical Volatility
HV 10-Day
89.08%
HV 20-Day
119.72%
HV 30-Day
112.59%
HV 60-Day
114.20%
HV Rank
—
Volatility is currently contracting
Data last updated: 4/10/2026